Ondřej Čermák - Concepedia

Author

Ondřej Čermák

Also Known As

Jianhua Zhu, O Cermak, Ondrej Cermak, Ondřej Čermák, Roman Miklik

Publications

804

Citations

H-Index

Concepts

All Affiliations

OČ

Ondřej Čermák is an author at Brigham and Women's Hospital specializing in atrial fibrillation, pharmacotherapy, and cardiovascular pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	296
2	Public Health	1	1	296
3	Pharmacology	1	1	296
4	Atrial Fibrillation	1	1	296
5	Cardiology	1	1	296

Ondřej Čermák

Publications

496

Citations

H-Index

Page 1

	Year	Citations
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly, The Lancet ThrombosisDose-finding Phase 2Cardiovascular DiseasePharmacologyCardiovascular Pharmacology	2022	296
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt, Circulation	2022	142
Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation† Michelle L. O’Donoghue, Christian T. Ruff, Robert P. Giugliano, European Heart Journal	2015	45
Variability of aortic blood flow predicts fluid responsiveness in spontaneously breathing healthy volunteers. Roman Škulec, Ondřej Čermák, Hana Skalická, PubMed	2009	13

Page 1